Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Nvs crawled date : 2021 - 05 - 10 save search
Global Active Pharmaceutical Ingredient (API) Market Report 2021-2025: Opportunities in Advancements in API Manufacturing, Growth in the CMOs, & Emergence of Biosimilars Market
Published: 2021-05-10 (Crawled : 12:15) - prnewswire.com
VTRS | $11.32 -0.09% -0.09% 4.4M
|
Health Technology
|
| O: 6.39%
H: 3.3%
C: 0.4%
PFE A | $25.91 0.19% -0.04% 34M
|
Health Technology
|
| O: 0.63%
H: 1.13%
C: 0.08%
NVS | $94.41 0.95% 0.0% 1.4M
|
Health Technology
|
| O: 0.05%
H: 0.37%
C: -0.02%
GSK | $40.5 -0.39% -0.03% 2.8M
|
Health Technology
|
| O: 0.76%
H: 0.27%
C: -0.28%
LLY | $750.77 -0.12% 0.0% 2.3M
|
Health Technology
|
| O: 0.38%
H: 0.22%
C: -0.72%
BMY | $48.51 0.48% 0.0% 12M
|
Health Technology
|
| O: 0.31%
H: 1.01%
C: 0.09%
ALB | $120.5 -1.7% 0.0% 1.9M
|
Process Industries
|
| O: 0.41%
H: 1.07%
C: -2.39%
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: 1.54%
H: 0.17%
C: -0.32%
cmo growth merge biosimilar
Attralus Therapeutics Appoints Mark Timney as CEO and Expands Leadership Team with New Executives
Published: 2021-05-10 (Crawled : 12:00) - biospace.com/
NVS | $94.41 0.95% 0.0% 1.4M
|
Health Technology
|
| O: 0.05%
H: 0.37%
C: -0.02%
NKTR | $1.56 -6.59% -7.05% 2.8M
|
Health Technology
|
| O: 0.35%
H: 0.4%
C: -2.18%
ceo leo
COVID-19 Impact Analysis on Sjogren's Syndrome Therapeutics Market | 3.68% YOY growth expected in 2021 | Technavio
Published: 2021-05-10 (Crawled : 11:00) - prnewswire.com
NVS | $94.41 0.95% 0.0% 1.4M
|
Health Technology
|
| O: 0.05%
H: 0.37%
C: -0.02%
JNJ | $147.59 0.05% 0.0% 8.5M
|
Health Technology
|
| O: 0.83%
H: 0.96%
C: 0.22%
ABBV | $161.67 -0.38% -0.04% 5.4M
|
Health Technology
|
| O: 0.54%
H: 0.7%
C: -0.14%
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: 1.54%
H: 0.17%
C: -0.32%
BIIB | $196.76 -0.72% -0.72% 1.2M
|
Health Technology
|
| O: 0.3%
H: 1.41%
C: 0.27%
covid growth syndros covid-19
Transactions in connection with share buy-back program
Published: 2021-05-10 (Crawled : 08:00) - globenewswire.com
NVS | $94.41 0.95% 0.0% 1.4M
|
Health Technology
|
| O: 0.05%
H: 0.37%
C: -0.02%
GMAB | $29.51 0.85% 0.85% 500K
|
Health Technology
|
| O: 0.48%
H: 0.4%
C: -0.9%
program
Gainers vs Losers
| 49% | 51% |
Top 10 Gainers
KAVL | $6.275 135.02% 57.45% 44M
|
Wholesale Trade
PXMD | $0.7375 79.09% 44.16% 4.5M
|
Health Technology
DYNT | $0.371 -5.12% 43.09% 3.3M
|
Health Technology
LGVN P 3 d | $2.94 73.96% 42.52% 57M
|
HUBC | $1.94 49.23% 32.99% 73M
|
n/a
SPCB | $0.4044 46.52% 31.75% 130M
|
Electronic Technology
ONVO | $1.34 32.66% 24.62% 54M
|
Health Technology
OMQS | $0.6869 32.1% 24.3% 3.6M
|
Professional, Scientific, and T...
SNPO | $10.555 29.67% 22.88% 4M
|
AMBI | $3.72 -26.77% 21.77% 9.8K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.